Anuh Pharma Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter
- September 9, 2026
- Posted by: Harsh Piplani
- Category: Results
Anuh Pharma share price Rs 98.10 on 9 September 2026, up 2.69%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 11.00 crore. Q2 FY26 base a profit of Rs 8.00 crore.
Quick Answer
The Anuh Pharma Q2 results date for FY27 is not confirmed, and Anuh Pharma Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 186.00 crore in revenue and a profit of Rs 8.00 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.
The Anuh Pharma Q2 results FY27 announcement is the next scheduled earnings event for Anuh Pharma Ltd., a maker of bulk drugs and active pharmaceutical ingredients, part of the SK Group. The stock traded at Rs 98.10 on the NSE on 9 September 2026, up 2.69% from the previous close of Rs 95.53, about 1.4% below its 52-week high of Rs 99.50 and 46.4% above its 52-week low of Rs 67.00.
What makes the Anuh Pharma Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 186.00 crore of revenue and a profit of Rs 8.00 crore, while the most recent quarter on record, Q1 FY27, produced Rs 194.00 crore and a profit of Rs 11.00 crore. Everything below is built from those reported figures rather than from any forecast.
Click Here – Get Free Investment Predictions
When Is the Anuh Pharma Q2 Results FY27 Date?
The Anuh Pharma Q2 results date for FY27 is not confirmed. As of 9 September 2026, Anuh Pharma Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.
What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Anuh Pharma Q2 results date becomes public through that filing rather than through any advance announcement.
The Anuh Pharma Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Anuh Pharma.
Anuh Pharma Q2 Results Expectations: What the Market Is Actually Tracking
No verified analyst estimate for the Anuh Pharma Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Anuh Pharma. The Anuh Pharma Q2 results watchlist below is built from what the company has actually reported and disclosed.
The first is the margin, which is the whole story here. Revenue barely moved across the five quarters, running between Rs 186 crore and Rs 202 crore, while operating margin went from 6% to 10% and profit from Rs 8 crore to Rs 13 crore.
The second is the September 2025 base of a 6% operating margin, the joint lowest of the five quarters. If margin holds anywhere near the recent 8% to 10% range, the year-on-year profit comparison should look comfortable.
The third is the tax charge. The June 2026 quarter carried a 32% rate against 23% to 25% earlier, which held profit at Rs 11 crore despite the second highest operating profit of the five.
Check Anuh Pharma Ltd. Live Fundamentals on the Univest Screener
Anuh Pharma Q2 Results Preview: The Q1 FY27 Actuals It Builds On
Anuh Pharma Ltd. reported revenue of Rs 194.00 crore in Q1 FY27, up 4.30% from Rs 186.00 crore in Q1 FY26, and a profit of Rs 11.00 crore at the net level, up 37.50% from Rs 8.00 crore in Q1 FY26. These are reported actuals, not estimates.
Sequentially, revenue was down 3.96% over the March 2026 quarter figure of Rs 202.00 crore, and net profit was down 8.33% from Rs 12.00 crore in Q4 FY26. Operating margin stood at 8% in Q1 FY27 against 6% in the September 2025 quarter, which is the comparison the Anuh Pharma Q2 results print will be read against.
Q2 FY26 Base: The Comparison Anuh Pharma Q2 Results FY27 Must Beat
Anuh Pharma Ltd. reported revenue of Rs 186.00 crore and a profit of Rs 8.00 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Anuh Pharma Q2 results preview.
Net profit in that base quarter was below the Rs 11.00 crore just reported for Q1 FY27, so the year-on-year comparison starts from a manageable level. Revenue of Rs 186.00 crore sits below the Rs 194.00 crore of the June 2026 quarter, which frames how much sequential movement the Anuh Pharma Q2 results print needs to show growth.
Anuh Pharma Quarterly Results Trend Over the Last Four Quarters
| Quarter | Revenue (Rs Cr) | Net Profit (Rs Cr) |
|---|---|---|
| Q2 FY26 (Sep 2025) | 186.00 | 8.00 |
| Q3 FY26 (Dec 2025) | 197.00 | 13.00 |
| Q4 FY26 (Mar 2026) | 202.00 | 12.00 |
| Q1 FY27 (Jun 2026) | 194.00 | 11.00 |
Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company’s exchange filings, and they are the only basis this Anuh Pharma Q2 results preview uses.
Revenue across those four quarters ranged from Rs 186.00 crore to Rs 202.00 crore, and net profit from Rs 8.00 crore to Rs 13.00 crore. That spread is the honest context for the Anuh Pharma Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.
Key Factors That Could Shape Anuh Pharma Q2 Results FY27
The Anuh Pharma Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Anuh Pharma has already reported.
Thin and Sensitive Operating Margin
At 6% to 10%, the operating margin means a small movement in input cost or realisation changes profit by a large proportion. Revenue stability makes margin the only variable that really moves the result.
Bulk Drug Pricing and Input Costs
Active ingredient prices and the cost of key starting materials both move on their own cycles, and much of the input chain runs through imports. The spread between the two is what the margin measures.
Debt-Free With a Rising Share Price
The company carries no borrowings against reserves of about Rs 302 crore, and the stock trades near its 52-week high of Rs 99.50 with a 14-day RSI of 82.08, well above both its moving averages.
Anuh Pharma Q2 Results FY27: Share Price and Valuation Going Into the Print
Anuh Pharma share price today is Rs 98.10 on the NSE, up Rs 2.57 or 2.69% from the previous close of Rs 95.53 on 9 September 2026, ahead of the Anuh Pharma Q2 results announcement.
| Metric | Value (9 September 2026) |
|---|---|
| NSE Symbol | ANUHPHR |
| Current Market Price | Rs 98.10 |
| 52-Week High | Rs 99.50 |
| 52-Week Low | Rs 67.00 |
| Market Capitalisation | Rs 978.94 crore |
| PE Ratio | 22.21 |
| PB Ratio | 2.79 |
| EPS (TTM) | Rs 4.42 |
| Book Value per Share | Rs 35.10 |
| Debt to Equity | 0.00 |
| Return on Equity | 10.70% |
| 50-Day Moving Average | Rs 80.12 |
| 200-Day Moving Average | Rs 78.45 |
| RSI (14) | 82.08 |
The stock trades above both its 50-day average of Rs 80.12 and its 200-day average of Rs 78.45, with a 14-day RSI of 82.08. None of this is a view on where the shares go once the Anuh Pharma Q2 results are announced, and no price target is offered here.
Download the Univest iOS App or Univest Android App to track Anuh Pharma Ltd. live price and quarterly earnings updates.
What Investors Should Watch When Anuh Pharma Q2 Results Are Announced
Four lines carry most of the information in a company of this size, and reading them in order keeps the Anuh Pharma Q2 results print in proportion.
- Revenue against the Rs 186.00 crore reported in the September 2025 base quarter
- Net profit against a profit of Rs 8.00 crore in that same quarter
- Operating margin against 8% in Q1 FY27
- Any exceptional item, provision or one-off gain disclosed alongside the numbers
A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Anuh Pharma Q2 results announcement should be read together with the notes to the results rather than the headline alone.
Conclusion on Anuh Pharma Q2 Results FY27
The Anuh Pharma Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Anuh Pharma Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.
On that basis the Anuh Pharma Q2 results FY27 print faces a base of Rs 186.00 crore in revenue and a profit of Rs 8.00 crore, with the most recent quarter having delivered Rs 194.00 crore and a profit of Rs 11.00 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Anuh Pharma, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Anuh Pharma Q2 Results FY27
What is the Anuh Pharma Q2 results date for FY27?
Ans. The Anuh Pharma Q2 results date for FY27 is not confirmed. Anuh Pharma Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.
What quarter do the Anuh Pharma Q2 results 2026 cover?
Ans. The Anuh Pharma Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Anuh Pharma Ltd. reports revenue, operating profit and net profit for that period, and the Anuh Pharma Q2 results filing also carries the notes to the accounts.
What were the Anuh Pharma Q1 FY27 results?
Ans. Anuh Pharma Ltd. reported revenue of Rs 194.00 crore in Q1 FY27 and a profit of Rs 11.00 crore at the net level. Revenue was up 4.30% versus Q1 FY26 and net profit was up 37.50% from Rs 8.00 crore in Q1 FY26.
What were Anuh Pharma Q2 FY26 results in the September 2025 quarter?
Ans. Anuh Pharma Ltd. reported revenue of Rs 186.00 crore and a profit of Rs 8.00 crore in Q2 FY26. Operating margin was 6%. Those figures form the base for the Anuh Pharma Q2 results FY27 comparison.
What are the main Anuh Pharma Q2 results expectations this quarter?
Ans. No verified analyst estimate is publicly available. The Anuh Pharma Q2 results expectations centre on revenue against the Rs 186.00 crore base, net profit against a profit of Rs 8.00 crore, operating margin against 8% in Q1 FY27, and any exceptional item disclosed with the numbers.
What is Anuh Pharma share price today ahead of the Q2 earnings?
Ans. Anuh Pharma share price is Rs 98.10 on the NSE as of 9 September 2026, up 2.69% from Rs 95.53. The stock is about 1.4% below its 52-week high of Rs 99.50 and 46.4% above its 52-week low of Rs 67.00, at a market capitalisation of Rs 978.94 crore.
Is Anuh Pharma a good stock to buy before the Q2 results?
Ans. This article does not offer a buy, sell or hold recommendation on Anuh Pharma Ltd.. The stock trades at a price-to-book ratio of 2.79 with a return on equity of 10.70%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.
